| Literature DB >> 27925693 |
Yasmeen Abouelhassan1, Akash Basak2, Hussain Yousaf1, Robert W Huigens1,2.
Abstract
Bacterial biofilms housing dormant persister cells are innately tolerant to antibiotics and disinfectants, yet several membrane-active agents are known to eradicate tolerant bacterial cells. NH125, a membrane-active persister killer and starting point for development, led to the identification of two N-arylated analogues (1 and 2) that displayed improved biofilm eradication potencies compared to the parent compound and rapid persister-cell-killing activities in stationary cultures of methicillin-resistant Staphylococcus aureus (MRSA). We found 1 and 2 to be superior to other membrane-active agents in biofilm eradication assays, with 1 demonstrating minimum biofilm eradication concentrations (MBEC) of 23.5, 11.7, and 2.35 μm against MRSA, methicillin-resistant Staphylococcus epidermidis (MRSE), and vancomycin-resistant Enterococcus faecium (VRE) biofilms, respectively. We tested our panel of membrane-active agents against MRSA stationary cultures and found 1 to rapidly eradicate MRSA stationary cells by 4 log units (99.99 %) in 30 min. The potent biofilm eradication and rapid persister-cell-killing activities exhibited by N-arylated NH125 analogues could have significant impact in addressing biofilm-associated problems.Entities:
Keywords: MRSA; antibacterial agents; biofilms; drug-resistant bacteria; persister cells
Mesh:
Substances:
Year: 2017 PMID: 27925693 DOI: 10.1002/cbic.201600622
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164